Metformin and Cancer: Is This the End?

Gallagher, Emily J; Kase, Nathan G; Bickell, Nina A; LeRoith, Derek

Gallagher, Emily J; Kase, Nathan G; Bickell, Nina A; LeRoith, Derek.

Afiliação

Gallagher EJ; Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: emily.gallagher@mssm.edu.
Kase NG; Department of Obstetrics, Gynecology, and Reproductive Science, Icahn School of Medicine at Mount Sinai, New York, New York.
Bickell NA; Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York; Department of Population Health Science and Policy, Center for Health Equity and Community-Engaged Research, Icahn School of Medicine at Mount Sinai, New York, New York.
LeRoith D; Division of Endocrinology, Diabetes and Bone Disease, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York; Tisch Cancer Institute at Mount Sinai, Icahn School of Medicine at Mount Sinai, New York, New York.

Endocr Pract ; 28(8): 832-834, 2022 08.

Article em En | MEDLINE | ID: mdl-35724834

Assuntos

Neoplasias da Mama; Resistência à Insulina; Metformina; Neoplasias; Feminino; Humanos; Hipoglicemiantes/efeitos adversos; Insulina; Metformina/uso terapêutico; Neoplasias/tratamento farmacológico

Palavras-chave

MA.32; breast cancer; insulin resistance; metformin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistência à Insulina / Metformina / Neoplasias Limite: Female / Humans Idioma: En Revista: Endocr Pract Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google